ResHealth 2017
completed
clinicaltrials
(Closed for recruitment)
COSMOS

MEA115661: A multi-centre, open-label, long-term safety study of mepolizumab in asthmatic subjects who participated in the MEA115588 or MEA115575 trials.

 Approved on the 21/05/2013
 Participants in the study 2
SUMMIT

A Clinical Outcomes Study to compare the effect of Fluticasone Furoate/ Vilanterol Inhalation Powder 100/25mcg with placebo on Survival in Subjects with moderate Chronic Obstructive Pulmonary Disease (COPD) and a history of or at increased risk for cardiovascular disease.

 Approved on the 05/08/2011
 Participants in the study 15
affiliated with
follow us
©Copyright 2017. Arasmi.org
Email: info@arasmi.org

Powered by Digital Wave Media